The appearance of a white, oblong pill marked with the imprint "M367" is a common sight in modern pain management. This specific marking identifies a high-strength generic version of Norco, a combination medication consisting of Hydrocodone Bitartrate and Acetaminophen. Manufactured primarily by Mallinckrodt Pharmaceuticals, the M367 pill is a Schedule II controlled substance, reflecting both its clinical utility and its significant potential for dependence. Understanding exactly what this tablet contains, how it functions, and the risks associated with its use is critical for anyone to whom it has been prescribed.

Visual Identification of the M367 Pill

Correct identification is the first step in medication safety. The M367 tablet possesses distinct physical characteristics that distinguish it from other doses in the same drug family:

  • Imprint: The characters "M367" are clearly stamped on one side of the pill. The "M" refers to the manufacturer, Mallinckrodt, while the "367" is the specific code for the 10 mg / 325 mg formulation.
  • Color: The pill is a uniform, stark white. Any discoloration, spotting, or "speckled" appearance may indicate a counterfeit or a degraded product.
  • Shape: It is capsule-shaped or oblong.
  • Score Line: On the side opposite the imprint, there is a single score line (a groove) that allows the pill to be split into two equal halves if a smaller dose is medically directed.
  • Size: The tablet typically measures approximately 15 mm in length.

In the current landscape of 2026, where counterfeit medications have become increasingly sophisticated, verifying these visual markers against a pharmacy-dispensed bottle is a primary safety protocol. Authentic tablets will have sharp, clean edges and a consistent professional finish. Crumbly edges or faded imprints should be treated as red flags.

The Chemical Profile: What Is Inside M367?

The M367 pill is a combination analgesic. It leverages two different mechanisms of action to manage moderate to moderately severe pain.

Hydrocodone Bitartrate (10 mg)

Hydrocodone is a semi-synthetic opioid derivative of codeine. It acts as a central nervous system (CNS) depressant. By binding to mu-opioid receptors in the brain and spinal cord, hydrocodone alters the perception of pain and the emotional response to it. At a 10 mg concentration, the M367 is considered a "high-strength" variant compared to its lower-dose siblings (M365 and M366).

Acetaminophen (325 mg)

Commonly known as APAP, acetaminophen is a non-opioid analgesic and antipyretic (fever reducer). While it is less effective than opioids for severe pain on its own, it acts as a synergist. When combined with hydrocodone, acetaminophen enhances the overall pain-relieving effect, allowing for a potentially lower dose of the opioid component than might otherwise be required. The 325 mg dosage is the standard maximum permitted by the FDA in combination products to reduce the risk of acute liver failure.

M367 vs. M365 vs. M366: Understanding the Strengths

Patients may encounter different versions of this medication depending on the severity of their condition. Mallinckrodt uses a sequential numbering system for their hydrocodone/acetaminophen line:

  1. M365: Contains 5 mg of Hydrocodone and 325 mg of Acetaminophen. This is typically the starting dose for mild to moderate pain.
  2. M366: Contains 7.5 mg of Hydrocodone and 325 mg of Acetaminophen. It serves as an intermediate step.
  3. M367: Contains 10 mg of Hydrocodone and 325 mg of Acetaminophen. This is the maximum strength available in this specific product line, reserved for more intense pain levels, such as post-surgical recovery or severe injury.

It is vital to note that while the hydrocodone amount increases, the acetaminophen amount remains constant at 325 mg. This is a deliberate safety design to prevent accidental acetaminophen overdose when stepping up to higher opioid strengths.

The 2026 Safety Reality: Authentic Pills vs. Counterfeits

As of April 2026, the illicit market for pressed pills has reached a point where visual inspection alone can sometimes be deceptive. Counterfeit "M367" pills found outside of legitimate pharmacy chains often contain fentanyl or other potent synthetic opioids rather than the indicated hydrocodone.

Authentic M367 pills produced by Mallinckrodt have a specific density and hardness. They do not easily crumble under light pressure. If a pill appears chalky, has an "off-white" or yellowish tint, or if the imprint looks rounded rather than sharp, it should not be consumed. The only way to ensure the safety of an M367 pill is to obtain it directly from a licensed pharmacist with a valid prescription.

How M367 Works: Pharmacokinetics and Duration

When ingested, the M367 pill is absorbed through the gastrointestinal tract. The effects typically begin within 30 to 60 minutes.

  • Peak Effect: The maximum pain relief usually occurs between 1 and 2 hours after administration.
  • Duration of Action: The analgesic effects generally last for 4 to 6 hours.
  • Metabolism: The drug is metabolized by the liver. Hydrocodone is converted into several metabolites, including hydromorphone, through the CYP2D6 enzyme pathway. Acetaminophen is also processed by the liver, which is why liver health is a primary concern for long-term users.

Because of this timeframe, doctors typically prescribe M367 to be taken every 4 to 6 hours as needed for pain. Exceeding this frequency can lead to a dangerous buildup of both the opioid and the acetaminophen in the bloodstream.

Medical Indications: When is M367 Prescribed?

The M367 white pill is not a first-line treatment for minor aches. It is indicated for pain that is severe enough to require an opioid and where alternative treatments (like ibuprofen or naproxen) are inadequate or cannot be tolerated. Common scenarios include:

  • Post-Operative Recovery: Managing pain following orthopedic, dental, or abdominal surgeries.
  • Severe Injury: Acute pain from fractures or significant soft tissue trauma.
  • Chronic Pain Management: In specific cases, such as cancer-related pain or severe degenerative joint disease, though current medical guidelines favor short-term use to prevent addiction.

Critical Side Effects and Management

Like all opioids, the M367 pill carries a profile of common and serious side effects.

Common Side Effects

  • Nausea and Vomiting: Often occurring during the first few doses. Taking the medication with food can mitigate this, though it may slightly delay the onset of pain relief.
  • Drowsiness and Dizziness: Users should avoid driving or operating heavy machinery until they understand how the drug affects them.
  • Constipation: Opioids slow down the digestive tract. This is a near-universal side effect for long-term users. Increasing fiber intake and staying hydrated are standard recommendations.

Serious Risks

  • Respiratory Depression: The most dangerous risk of hydrocodone is slowed or shallow breathing. This is the primary cause of death in opioid overdoses.
  • Hepatotoxicity (Liver Damage): Due to the acetaminophen component, taking more than the prescribed amount or combining M367 with other products containing acetaminophen can lead to severe liver injury.
  • Adrenal Insufficiency: Long-term use may affect how the body produces cortisol.

Interactions to Avoid

The M367 pill can interact dangerously with other substances. The most critical interaction is with alcohol. Alcohol increases the sedative effects of hydrocodone and significantly raises the risk of fatal respiratory depression. Furthermore, the combination of alcohol and acetaminophen is highly toxic to the liver.

Other dangerous interactions include:

  • Benzodiazepines (e.g., Xanax, Valium): Combining these with M367 can lead to extreme sedation, coma, or death.
  • Other CNS Depressants: Sleep medications or muscle relaxants.
  • MAO Inhibitors: Can cause unpredictable and severe reactions.

Tolerance, Dependence, and Withdrawal

Because M367 contains hydrocodone, it is a habit-forming medication.

  1. Tolerance: Over time, the body may require higher doses to achieve the same level of pain relief. This should only be managed by a physician.
  2. Physical Dependence: The body becomes accustomed to the presence of the drug. Stopping abruptly after prolonged use often leads to withdrawal symptoms such as restlessness, muscle aches, sweating, and anxiety.
  3. Opioid Use Disorder (OUD): Psychological addiction involves a craving for the drug for reasons other than pain relief.

To minimize these risks, M367 is usually prescribed for the shortest duration possible. If a patient has been on M367 for an extended period, a gradual tapering schedule is the standard medical approach to discontinuation.

Proper Storage and Disposal

Given the strength of the M367 10/325 mg pill, storage is a matter of public safety. It should be kept in its original, child-resistant container in a secure location, ideally a locked cabinet. Accidental ingestion by children or pets can be fatal.

If medication is left over after the pain has resolved, it should not be saved "just in case." Many communities offer drug take-back programs. If these are unavailable, certain high-risk medications like M367 are on the FDA's "flush list," meaning they should be flushed down the toilet to prevent accidental poisoning or intentional misuse by others in the household.

Summary of Key Facts for M367

  • Identification: White, oblong, imprinted "M367".
  • Dose: 10 mg Hydrocodone / 325 mg Acetaminophen.
  • Type: Schedule II Narcotic Analgesic.
  • Maximum Dose: Generally not more than 6 tablets in a 24-hour period (to stay under the 2000-3000 mg acetaminophen limit usually recommended by doctors, though the absolute limit is 4000 mg).
  • Primary Danger: Respiratory depression and liver toxicity.

When used exactly as directed by a healthcare professional, the M367 pill is a highly effective tool for managing significant pain. However, the responsibility of the patient involves strict adherence to dosage, awareness of side effects, and proactive communication with their medical provider regarding any concerns about efficacy or dependence. In the evolving medical environment of 2026, staying informed is the most effective way to ensure that pain management remains both safe and effective.